FibroGen Company

FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer.

Industry: Genomic and Epigenominc Instabillity
Investor Type: N/A
Headquarters: United States
Investment Stage: N/A
Funding Status: IPO
Employee Number: 251-500
Number Of Exists: N/A
Technology: Drug Delivery
Estimated Revenue: $10M to $50M
Founded Date: 1993